The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAdvanced Medical Solutions Group Regulatory News (AMS)

Share Price Information for Advanced Medical Solutions Group (AMS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 203.50
Bid: 201.00
Ask: 203.00
Change: 1.00 (0.49%)
Spread: 2.00 (0.995%)
Open: 200.00
High: 207.50
Low: 200.00
Prev. Close: 202.50
AMS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

20 Dec 2012 17:43

RNS Number : 0872U
Advanced Medical Solutions Grp PLC
20 December 2012
 

 

 

TR-1: Notifications of Major Interests in Shares

 

1: Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Advanced Medical Solutions Group PLC

 

2: Reason for notification (yes/no)

An acquisition or disposal of voting rights

yes

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

no

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

no

An event changing the breakdown of voting rights

no

Other (please specify):

 

no

 

3. Full name of person(s) subject to the notification

obligation:

 Standard Life Investments Ltd

4. Full name of shareholder(s) (if different from 3.):

 Vidacos Nominees

5. Date of the transaction (and date on which the threshold

is crossed or reached):

19 December 2012

6. Date on which issuer notified:

20 December 2012

7. Threshold(s) that is/are crossed or reached:

5%

 

 

8: Notified Details
A: Voting rights attached to shares
Class/type of share If possible use ISIN code
GB0004536594
 
Situation previous to the triggering transaction
Number of shares
Number of voting rights
11,326,500
11,326,500
 
Resulting situation after the triggering transaction
Number of shares
Number of voting rights
Percentage ofvoting rights
Direct
Indirect
Direct
Indirect
8,570,000
0%
8,570,000
0%
4.190%
 

B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument
Expiration date
Exercise/ conversion period/date
No. of voting rights that may be acquired(if the instrument exercised/converted)
Percentage of voting rights
 
 
 
 
 
 

 

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financialinstrument

Exerciseprice

Expirationdate

Exercise/Conversionperiod

Number of votingrights instrumentrefers to

% of voting rights

 

 

 

 

 

 

Nominal

Delta

 

 

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

8,570,000

4.190%

 

 

 

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable:

 

Proxy Voting:

 

10. Name of the proxy holder:

 

11. Number of voting rights proxy holder will cease to hold:

 

12. Date on which proxy holder will cease to hold voting rights:

 

 

13. Additional information:

 

14. Contact name:

 

investments_mo@standardlife.comStandard Life Investments Ltd

15. Contact telephone number:

 

(0131) 245 6565

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLURSBRUUAUUAA
Date   Source Headline
1st May 20249:10 amRNSTotal Voting Rights
26th Apr 20249:17 amRNSDirector/PDMR Shareholding
25th Apr 20243:41 pmRNSHolding(s) in Company
17th Apr 20243:30 pmRNSHolding(s) in Company
4th Apr 20243:17 pmRNSHolding(s) in Company
2nd Apr 20242:47 pmRNSDirector/PDMR and PCA Shareholding
28th Mar 20245:04 pmRNSTotal Voting Rights
18th Mar 202412:35 pmRNSDirector/PDMR Shareholding
13th Mar 20247:03 amRNSProposed acquisition of Peters Surgical
13th Mar 20247:03 amRNSUnaudited Preliminary Results
12th Mar 20247:00 amRNSBlock listing Interim Review
10th Jan 20247:00 amRNSFull Year Trading Update
30th Nov 20235:11 pmRNSTotal Voting Rights
31st Oct 20235:02 pmRNSTotal Voting Rights
25th Oct 20237:00 amRNSUS LiquiBand® distribution agreements signed
2nd Oct 20237:01 amRNSDirector/PDMR Shareholding
2nd Oct 20237:00 amRNSAppointment of New Chair
27th Sep 20235:55 pmRNSDirector/PDMR Shareholding
25th Sep 20233:15 pmRNSHolding(s) in Company
20th Sep 20237:00 amRNSInterim Results
18th Sep 20237:00 amRNSLiquiBand Fix8® US commercialisation agreement
14th Sep 20233:52 pmRNSBlock listing Interim Review
4th Sep 20237:00 amRNSTrading Statement
31st Aug 20235:56 pmRNSTotal Voting Rights
10th Aug 20237:00 amRNSNotice of Interim Results
31st Jul 20234:51 pmRNSTotal Voting Rights
11th Jul 20237:00 amRNSHalf Year Trading Update
30th Jun 20232:14 pmRNSTotal Voting Rights
19th Jun 202312:18 pmRNSStandard form for notification of major holdings
5th Jun 20237:00 amRNSUS regulatory approval granted for LiquiBandFix8®
31st May 20232:08 pmRNSResults of Annual General Meeting
31st May 20237:00 amRNSAnnual General Meeting
22nd May 20236:13 pmRNSDirector/PDMR Shareholding
28th Apr 20235:57 pmRNSTotal Voting Rights
26th Apr 20235:37 pmRNSAnnual Report and Notice of Annual General Meeting
18th Apr 20236:22 pmRNSDirector/PDMR Shareholding
3rd Apr 202312:41 pmRNSTotal Voting Rights
27th Mar 20235:56 pmRNSDirector/PDMR and PCA Shareholding
22nd Mar 20235:52 pmRNSDirector/PDMR Shareholding
15th Mar 20237:00 amRNSUnaudited Preliminary Results
8th Mar 20232:56 pmRNSBlock listing announcement
28th Feb 20235:56 pmRNSTotal Voting Rights
14th Feb 20237:01 amRNSNotice of Results
1st Feb 20231:30 pmRNSAcquisition of Connexicon Medical
31st Jan 20233:17 pmRNSTotal Voting Rights
10th Jan 20237:00 amRNSFull Year Trading Update
3rd Jan 20237:00 amRNSTotal Voting Rights
30th Nov 20226:04 pmRNSTotal Voting Rights
28th Nov 20224:20 pmRNSChange of Registrar
31st Oct 20227:00 amRNSLiquiBandFix8® PMA application accepted by FDA

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.